<?xml version="1.0" encoding="UTF-8" standalone="no" ?>
<rss version="2.0">
  <channel>
    <title>Grootegoed, J.A.</title>
    <link>http://repub.eur.nl/res/aut/627/</link>
    <description>List of Publications</description>
    <language>en</language>
    <image>
      <url>http://repub.eur.nl/static-eur/img/logo.png</url>
      <title>RePub, Erasmus University Rotterdam</title>
      <link>http://repub.eur.nl</link>
    </image>
    <item>
      <title>Precise BAC targeting of genetically polymorphic mouse ES cells (Article)</title>
      <link>http://repub.eur.nl/res/pub/33830/</link>
      <pubDate>2011-10-01T00:00:00Z</pubDate>
      <description>The use of bacterial artificial chromosomes (BACs) provides a consistent and high targeting efficiency of homologous recombination in embryonic stem (ES) cells, facilitated by long stretches of sequence homology. Here, we introduce a BAC targeting method which employs restriction fragment length polymorphisms (RFLPs) in targeted polymorphic C57BL/6/Cast/Ei F1 mouse ES cell lines to identify properly targeted ES cell clones. We demonstrate that knockout alleles can be generated either by targeting of an RFLP located in the open reading frame thereby disrupting the RFLP and ablating gene function, or by introduction of a transcription stop cassette that prematurely stops transcription of an RFLP located downstream of the stop cassette. With both methods we have generated Rnf12 heterozygous knockout ES cells, which were identified by allele specific PCR using genomic DNA or cDNA as a template. Our results indicate that this novel strategy is efficient and precise, by combining a high targeting efficiency with a convenient PCR based readout and reliable detection of correct targeting events. </description>
    </item> <item>
      <title>Human RAD18 interacts with ubiquitylated chromatin components and facilitates RAD9 recruitment to DNA double strand breaks (Article)</title>
      <link>http://repub.eur.nl/res/pub/31143/</link>
      <pubDate>2011-08-22T00:00:00Z</pubDate>
      <description>RAD18 is an ubiquitin ligase involved in replicative damage bypass and DNA double-strand break (DSB) repair processes. We found that RPA is required for the dynamic pattern of RAD18 localization during the cell cycle, and for accumulation of RAD18 at sites of γ-irradiation-induced DNA damage. In addition, RAD18 colocalizes with chromatin-associated conjugated ubiquitin and ubiquitylated H2A throughout the cell cycle and following irradiation. This localization pattern depends on the presence of an intact, ubiquitin-binding Zinc finger domain. Using a biochemical approach, we show that RAD18 directly binds to ubiquitylated H2A and several other unknown ubiquitylated chromatin components. This interaction also depends on the RAD18 Zinc finger, and increases upon the induction of DSBs by γ-irradiation. Intriguingly, RAD18 does not always colocalize with regions that show enhanced H2A ubiquitylation. In human female primary fibroblasts, where one of the two X chromosomes is inactivated to equalize X-chromosomal gene expression between male (XY) and female (XX) cells, this inactive X is enriched for ubiquitylated H2A, but only rarely accumulates RAD18. This indicates that the binding of RAD18 to ubiquitylated H2A is context-dependent. Regarding the functional relevance of RAD18 localization at DSBs, we found that RAD18 is required for recruitment of RAD9, one of the components of the 9-1-1 checkpoint complex, to these sites. Recruitment of RAD9 requires the functions of the RING and Zinc finger domains of RAD18. Together, our data indicate that association of RAD18 with DSBs through ubiquitylated H2A and other ubiquitylated chromatin components allows recruitment of RAD9, which may function directly in DSB repair, independent of downstream activation of the checkpoint kinases CHK1 and CHK2. </description>
    </item> <item>
      <title>Meiotic functions of RAD18 (Article)</title>
      <link>http://repub.eur.nl/res/pub/31231/</link>
      <pubDate>2011-08-15T00:00:00Z</pubDate>
      <description>RAD18 is an ubiquitin ligase that is involved in replication damage bypass and DNA double-strand break (DSB) repair processes in mitotic cells. Here, we investigated the testicular phenotype of Rad18-knockdown mice to determine the function of RAD18 in meiosis, and in particular, in the repair of meiotic DSBs induced by the meiosis-specific topoisomerase-like enzyme SPO11. We found that RAD18 is recruited to a specific subfraction of persistent meiotic DSBs. In addition, RAD18 is recruited to the chromatin of the XY chromosome pair, which forms the transcriptionally silent XY body. At the XY body, RAD18 mediates the chromatin association of its interaction partners, the ubiquitin-conjugating enzymes HR6A and HR6B. Moreover, RAD18 was found to regulate the level of dimethylation of histone H3 at Lys4 and maintain meiotic sex chromosome inactivation, in a manner similar to that previously observed for HR6B. Finally, we show that RAD18 and HR6B have a role in the efficient repair of a small subset of meiotic DSBs. </description>
    </item> <item>
      <title>Sex and gender issues in competitive sports: Investigation of a historical case leads to a new viewpoint (Article)</title>
      <link>http://repub.eur.nl/res/pub/25757/</link>
      <pubDate>2011-05-03T00:00:00Z</pubDate>
      <description>Based on DNA analysis of a historical case, the authors describe how a female athlete can be unknowingly confronted with the consequences of a disorder of sex development resulting in hyperandrogenism emerging early in her sports career. In such a situation, it is harmful and confusing to question sex and gender. Exposure to either a low or high level of endogenous testosterone from puberty is a decisive factor with respect to sexual dimorphism of physical performance. Yet, measurement of testosterone is not the means by which questions of an athlete's eligibility to compete with either women or men are resolved. The authors discuss that it might be justifiable to use the circulating testosterone level as an endocrinological parameter, to try to arrive at an objective criterion in evaluating what separates women and men in sports competitions, which could prevent the initiation of complicated, lengthy and damaging sex and gender verification procedures. Copyright Article author (or their employer) 2011.</description>
    </item> <item>
      <title>RNF12 activates Xist and is essential for X chromosome inactivation (Article)</title>
      <link>http://repub.eur.nl/res/pub/22817/</link>
      <pubDate>2011-02-15T00:00:00Z</pubDate>
      <description>In somatic cells of female placental mammals, one of the two X chromosomes is transcriptionally silenced to accomplish an equal dose of X-encoded gene products in males and females. Initiation of random X chromosome inactivation (XCI) is thought to be regulated by X-encoded activators and autosomally encoded suppressors controlling Xist. Spreading of Xist RNA leads to silencing of the X chromosome in cis. Here, we demonstrate that the dose dependent X-encoded XCI activator RNF12/RLIM acts in trans and activates Xist. We did not find evidence for RNF12-mediated regulation of XCI through Tsix or the Xist intron 1 region, which are both known to be involved in inhibition of Xist. In addition, we found that Xist intron 1, which contains a pluripotency factor binding site, is not required for suppression of Xist in undifferentiated ES cells. Analysis of female Rnf12-/- knockout ES cells showed that RNF12 is essential for initiation of XCI and is mainly involved in the regulation of Xist. We conclude that RNF12 is an indispensable factor in up-regulation of Xist transcription, thereby leading to initiation of random XCI.</description>
    </item> <item>
      <title>RNF12 activates Xist and is essential for X chromosome inactivation (Article)</title>
      <link>http://repub.eur.nl/res/pub/23995/</link>
      <pubDate>2011-02-15T00:00:00Z</pubDate>
      <description>In somatic cells of female placental mammals, one of the two X chromosomes is transcriptionally silenced to accomplish an equal dose of X-encoded gene products in males and females. Initiation of random X chromosome inactivation (XCI) is thought to be regulated by X-encoded activators and autosomally encoded suppressors controlling Xist. Spreading of Xist RNA leads to silencing of the X chromosome in cis. Here, we demonstrate that the dose dependent X-encoded XCI activator RNF12/RLIM acts in trans and activates Xist. We did not find evidence for RNF12-mediated regulation of XCI through Tsix or the Xist intron 1 region, which are both known to be involved in inhibition of Xist. In addition, we found that Xist intron 1, which contains a pluripotency factor binding site, is not required for suppression of Xist in undifferentiated ES cells. Analysis of female Rnf12-/-knockout ES cells showed that RNF12 is essential for initiation of XCI and is mainly involved in the regulation of Xist. We conclude that RNF12 is an indispensable factor in up-regulation of Xist transcription, thereby leading to initiation of random XCI. </description>
    </item> <item>
      <title>The ubiquitin-conjugating enzyme HR6B is required for maintenance of X chromosome silencing in mouse spermatocytes and spermatids (Article)</title>
      <link>http://repub.eur.nl/res/pub/28429/</link>
      <pubDate>2010-06-10T00:00:00Z</pubDate>
      <description>Background: The ubiquitin-conjugating enzyme HR6B is required for spermatogenesis in mouse. Loss of HR6B results in aberrant histone modification patterns on the trancriptionally silenced X and Y chromosomes (XY body) and on centromeric chromatin in meiotic prophase. We studied the relationship between these chromatin modifications and their effects on global gene expression patterns, in spermatocytes and spermatids.Results: HR6B is enriched on the XY body and on centromeric regions in pachytene spermatocytes. Global gene expression analyses revealed that spermatid-specific single- and multicopy X-linked genes are prematurely expressed in Hr6b knockout spermatocytes. Very few other differences in gene expression were observed in these cells, except for upregulation of major satellite repeat transcription. In contrast, in Hr6b knockout spermatids, 7298 genes were differentially expressed; 65% of these genes was downregulated, but we observed a global upregulation of gene transcription from the X chromosome. In wild type spermatids, approximately 20% of the single-copy X-linked genes reach an average expression level that is similar to the average expression from autosomes.Conclusions: Spermatids maintain an enrichment of repressive chromatin marks on the X chromosome, originating from meiotic prophase, but this does not interfere with transcription of the single-copy X-linked genes that are reactivated or specifically activated in spermatids. HR6B represses major satellite repeat transcription in spermatocytes, and functions in the maintenance of X chromosome silencing in spermatocytes and spermatids. It is discussed that these functions involve modification of chromatin structure, possibly including H2B ubiquitylation. </description>
    </item> <item>
      <title>Meiotic silencing and fragmentation of the male germline restricted chromosome in zebra finch (Article)</title>
      <link>http://repub.eur.nl/res/pub/18552/</link>
      <pubDate>2010-06-01T00:00:00Z</pubDate>
      <description>During male meiotic prophase in mammals, X and Y are in a largely unsynapsed configuration, which is thought to trigger meiotic sex chromosome inactivation (MSCI). In avian species, females are ZW, and males ZZ. Although Z and W in chicken oocytes show complete, largely heterologous synapsis, they too undergo MSCI, albeit only transiently. The W chromosome is already inactive in early meiotic prophase, and inactive chromatin marks may spread on to the Z upon synapsis. Mammalian MSCI is considered as a specialised form of the general meiotic silencing mechanism, named meiotic silencing of unsynapsed chromatin (MSUC). Herein, we studied the avian form of MSUC, by analysing the behaviour of the peculiar germline restricted chromosome (GRC) that is present as a single copy in zebra finch spermatocytes. In the female germline, this chromosome is present in two copies, which normally synapse and recombine. In contrast, during male meiosis, the single GRC is always eliminated. We found that the GRC in the male germline is silenced from early leptotene onwards, similar to the W chromosome in avian oocytes. The GRC remains largely unsynapsed throughout meiotic prophase I, although patches of SYCP1 staining indicate that part of the GRC may self-synapse. In addition, the GRC is largely devoid of meiotic double strand breaks. We observed a lack of the inner centromere protein INCENP on the GRC and elimination of the GRC following metaphase I. Subsequently, the GRC forms a micronucleus in which the DNA is fragmented. We conclude that in contrast to MSUC in mammals, meiotic silencing of this single chromosome in the avian germline occurs prior to, and independent of DNA double strand breaks and chromosome pairing, hence we have named this phenomenon meiotic silencing prior to synapsis (MSPS).</description>
    </item> <item>
      <title>Functional transformation of the chromatoid body in mouse spermatids requires testis-specific serine/threonine kinases (Article)</title>
      <link>http://repub.eur.nl/res/pub/19524/</link>
      <pubDate>2010-02-01T00:00:00Z</pubDate>
      <description>The cytoplasmic chromatoid body (CB) organizes mRNA metabolism and small regulatory RNA pathways, in relation to haploid gene expression, in mammalian round spermatids. However, little is known about functions and fate of the CB at later steps of spermatogenesis, when elongating spermatids undergo chromatin compaction and transcriptional silencing. In mouse elongating spermatids, we detected accumulation of the testis-specific serine/threonine kinases TSSK1 and TSSK2, and the substrate TSKS, in a ring-shaped structure around the base of the flagellum and in a cytoplasmic satellite, both corresponding to structures described to originate from the CB. At later steps of spermatid differentiation, the ring is found at the caudal end of the newly formed mitochondrial sheath. Targeted deletion of the tandemly arranged genes Tssk1 and Tssk2 in mouse resulted in male infertility, with loss of the CB-derived ring structure, and with elongating spermatids possessing a collapsed mitochondrial sheath. These results reveal TSSK1- and TSSK2-dependent functions of a transformed CB in post-meiotic cytodifferentiation of spermatids.</description>
    </item> <item>
      <title>RNF12 Is an X-Encoded Dose-Dependent Activator of X Chromosome Inactivation (Article)</title>
      <link>http://repub.eur.nl/res/pub/24304/</link>
      <pubDate>2009-11-25T00:00:00Z</pubDate>
      <description>In somatic cells of female placental mammals, one X chromosome is inactivated to minimize sex-related dosage differences of X-encoded genes. Random X chromosome inactivation (XCI) in the embryo is a stochastic process, in which each X has an independent probability to initiate XCI, triggered by the nuclear concentration of one or more X-encoded XCI-activators. Here, we identify the E3 ubiquitin ligase RNF12 as an important XCI-activator. Additional copies of mouse Rnf12 or human RNF12 result in initiation of XCI in male mouse ES cells and on both X chromosomes in a substantial percentage of female mouse ES cells. This activity is dependent on an intact open reading frame of Rnf12 and correlates with the transgenic expression level of RNF12. Initiation of XCI is markedly reduced in differentiating female heterozygous Rnf12+/-ES cells. These findings provide evidence for a dose-dependent role of RNF12 in the XCI counting and initiation process. </description>
    </item> <item>
      <title>Progesterone inhibition of Wnt/β-catenin signaling in normal endometrium and endometrial cancer (Article)</title>
      <link>http://repub.eur.nl/res/pub/17497/</link>
      <pubDate>2009-09-15T00:00:00Z</pubDate>
      <description>Purpose. Wnt signaling regulates the fine balance between stemness and differentiation. Here, the role of Wnt signaling to maintain the balance between estrogen-induced proliferation and progesterone-induced differentiation during the menstrual cycle, as well as during the induction of hyperplasia and carcinogenesis of the endometrium, was investigated. Experimental Design: Endometrial gene expression profiles from estradiol (E2) and E 2 + medroxyprogesterone acetate-treated postmenopausal patients were combined with profiles obtained during the menstrual cycle (PubMed; GEO DataSets). Ishikawa cells were transfected with progesterone receptors and Wnt inhibitors dickkopf homologue 1 (DKK1) and forkhead box O1 (FOXO1), measuring Wnt activation. Expression of DKK1 and FOXO1 was inhibited by use of sequence-specific short hairpins. Furthermore, patient samples (hormone-treated endometria, hyperplasia, and endometrial cancer) were stained for Wnt activation using nuclear β-catenin and CD44. Results: In vivo, targets and components of the Wnt signaling pathway (among them DKK1 and FOXO1) are regulated by E2 and progesterone. In Wnt-activated Ishikawa cells, progesterone inhibits Wnt signaling by induction of DKK1 and FOXO1. Furthermore, using siRNA-mediated knockdown of both DKK1 and FOXO1, progesterone inhibition of Wnt signaling was partly circumvented. Subsequently, immunohistochemical analysis of the Wnt target gene CD44 showed that progesterone acted as an inhibitor of Wnt signaling in hyperplasia and in well-differentiated endometrial cancer. Conclusion: Progesterone induction of DKK1 and FOXO1 results in inhibition of Wnt signaling in the human endometrium. This Wnt inhibitory effect of progesterone is likely to play a rate-limiting role in the maintenance of endometrial homeostasis and, on its loss, in tumor onset and progression toward malignancy.</description>
    </item> <item>
      <title>The probability to initiate X chromosome inactivation is determined by the X to autosomal ratio and X chromosome specific allelic properties (Article)</title>
      <link>http://repub.eur.nl/res/pub/16524/</link>
      <pubDate>2009-05-19T00:00:00Z</pubDate>
      <description>Background: In female mammalian cells, random X chromosome inactivation (XCI) equalizes the dosage of X-encoded gene products to that in male cells. XCI is a stochastic process, in which each X chromosome has a probability to be inactivated. To obtain more insight in the factors setting up this probability, we studied the role of the X to autosome (X:A) ratio in initiation of XCI, and have used the experimental data in a computer simulation model to study the cellular population dynamics of XCI. Methodology/Principal Findings: To obtain more insight in the role of the X:A ratio in initiation of XCI, we generated triploid mouse ES cells by fusion of haploid round spermatids with diploid female and male ES cells. These fusion experiments resulted in only XXY triploid ES cells. XYY and XXX ES lines were absent, suggesting cell death related either to insufficient X-chromosomal gene dosage (XYY) or to inheritance of an epigenetically modified X chromosome (XXX). Analysis of active (Xa) and inactive (Xi) X chromosomes in the obtained triploid XXY lines indicated that the initiation frequency of XCI is low, resulting in a mixed population of XaXiY and XaXaY cells, in which the XaXiY cells have a small proliferative advantage. This result, and findings on XCI in diploid and tetraploid ES cell lines with different X:A ratios, provides evidence that the X:A ratio determines the probability for a given X chromosome to be inactivated. Furthermore, we found that the kinetics of the XCI process can be simulated using a probability for an X chromosome to be inactivated that is proportional to the X:A ratio. These simulation studies re-emphasize our hypothesis that the probability is a function of the concentration of an X-encoded activator of XCI, and of X chromosome specific allelic properties determining the threshold for this activator. Conclusions: The present findings reveal that the probability for an X chromosome to be inactivated is proportional to the X:A ratio. This finding supports the presence of an X-encoded activator of the XCI process.</description>
    </item> <item>
      <title>Female meiotic sex chromosome inactivation in chicken (Article)</title>
      <link>http://repub.eur.nl/res/pub/24974/</link>
      <pubDate>2009-05-01T00:00:00Z</pubDate>
      <description>During meiotic prophase in male mammals, the heterologous X and Y chromosomes remain largely unsynapsed, and meiotic sex chromosome inactivation (MSCI) leads to formation of the transcriptionally silenced XY body. In birds, the heterogametic sex is female, carrying Z and W chromosomes (ZW), whereas males have the homogametic ZZ constitution. During chicken oogenesis, the heterologous ZW pair reaches a state of complete heterologous synapsis, and this might enable maintenance of transcription of Z- and W chromosomal genes during meiotic prophase. Herein, we show that the ZW pair is transiently silenced, from early pachytene to early diplotene using immunocytochemistry and gene expression analyses. We propose that ZW inactivation is most likely achieved via spreading of heterochromatin from the W on the Z chromosome. Also, persistent meiotic DNA double-strand breaks (DSBs) may contribute to silencing of Z. Surprisingly, γH2AX, a marker of DSBs, and also the earliest histone modification that is associated with XY body formation in mammalian and marsupial spermatocytes, does not cover the ZW during the synapsed stage. However, when the ZW pair starts to desynapse, a second wave of γH2AX accumulates on the unsynapsed regions of Z, which also show a reappearance of the DSB repair protein RAD51. This indicates that repair of meiotic DSBs on the heterologous part of Z is postponed until late pachytene/diplotene, possibly to avoid recombination with regions on the heterologously synapsed W chromosome. Two days after entering diplotene, the Z looses γH2AX and shows reactivation. This is the first report of meiotic sex chromosome inactivation in a species with female heterogamety, providing evidence that this mechanism is not specific to spermatogenesis. It also indicates the presence of an evolutionary force that drives meiotic sex chromosome inactivation independent of the final achievement of synapsis. </description>
    </item> <item>
      <title>Dynamic localization of human RAD18 during the cell cycle and a functional connection with DNA double-strand break repair (Article)</title>
      <link>http://repub.eur.nl/res/pub/24318/</link>
      <pubDate>2009-02-01T00:00:00Z</pubDate>
      <description>The ubiquitin ligase RAD18 is involved in different DNA repair processes. Here, we show that in G1 phase, human RAD18 accumulates in a few relatively large spontaneous foci that contain proteins involved in double-strand break (DSB) repair. These foci persist until cells enter S phase, when numerous small foci appear. At these sites, only 20% of RAD18 colocalizes with PCNA, a known RAD18 substrate. In late G2 phase, RAD18 relocates to nucleoli. After UVC irradiation, PCNA accumulates at the damaged site, followed by RAD18, independent of the cell cycle phase. After induction of DSBs, using low-power multi-photon laser, RAD18 accumulated at the DSB sites, but no PCNA accumulation was observed. Our data show that RAD18 accumulates on DSBs independent of the cell cycle phase. DSBs marked by RAD18 and RAD51 are also positive for RPA in G1 phase, and these DSBs persist until S phase. In addition, we show that DSBs generated in G2 phase are not all repaired, and are observed again in the next G1 phase. We conclude that repair of induced and spontaneous DSBs that accumulate RAD18 and RAD51 in G1 phase cells is delayed until S phase. </description>
    </item> <item>
      <title>DNA dependent recruitment of DDX17 and other interacting proteins by the human androgen receptor (Article)</title>
      <link>http://repub.eur.nl/res/pub/26983/</link>
      <pubDate>2009-02-01T00:00:00Z</pubDate>
      <description>An oligonucleotide-based assay (OBA) was used to identify novel co-factors that can be recruited by the deoxyribonucleic acid (DNA)-bound androgen receptor (AR). Nuclear extracts obtained from LNCaP cells, after incubation with R1881, were incubated with biotinylated oligonucleotides bound to streptavidin coated beads. The oligonucleotides contain 3 copies in tandem of the androgen responsive element ARE1 from the prostate specific antigen (PSA) gene promoter. As control incubation, a scrambled version of the tandem ARE1 was used. Immunoblots of the eluents revealed that the AR was bound to the ARE1 oligonucleotide and to a much lesser extent to the scrambled oligonucleotide. Proteins eluted from the oligonucleotides, were separated on a 5-15% sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) gradient gel, followed by identification using mass spectrometry. Identified proteins were scored for having one or more of the following known properties: nuclear localization, involved in transcription regulation, involvement in steroid hormone receptor (SHR) function, or specifical involvement in AR function. A total number of 85 nuclear proteins were found in two separate OBAs. Based on peptide counting, we found enrichment of 7 proteins eluted from the ARE1 oligonucleotide, compared to the scrambled oligonucleotide. Taken together with the obtained scores, these proteins are considered putative AR co-factors. One of these proteins, DDX17, is known to be a co-factor for estrogen receptor α (ERα), but has never been associated with AR function. The results indicate that the ARE oligonucleotide-based assay may allow enrichment of new candidate DNA-bound AR interacting proteins. Crown Copyright </description>
    </item> <item>
      <title>Our genome in the male germ line: Is it safe? (Article)</title>
      <link>http://repub.eur.nl/res/pub/18247/</link>
      <pubDate>2009-01-01T00:00:00Z</pubDate>
      <description></description>
    </item> <item>
      <title>A novel mutation F826L in the human androgen receptor in partial androgen insensitivity syndrome; increased NH2-/COOH-terminal domain interaction and TIF2 co-activation (Article)</title>
      <link>http://repub.eur.nl/res/pub/29654/</link>
      <pubDate>2008-09-24T00:00:00Z</pubDate>
      <description>A novel mutation F826L located within the ligand binding domain (LBD) of the human androgen receptor (AR) was investigated. This mutation was found in a boy with severe penoscrotal hypospadias (classified as 46,XY DSD). The AR mutant F826L appeared to be indistinguishable from the wild-type AR, with respect to ligand binding affinity, transcriptional activation of MMTV-luciferase and ARE2-TATA-luciferase reporter genes, protein level in genital skin fibroblasts (GSFs), and sub-cellular distribution in transfected cells. However, an at least two-fold higher NH2-/COOH-terminal domain interaction was found in luciferase and GST pull-down assays. A two-fold increase was also observed for TIF2 (transcription intermediary factor 2) co-activation of the AR F826L COOH-terminal domain. This increase could not be explained by a higher stability of the mutant protein, which was within wild-type range. Repression of transactivation by the nuclear receptor co-repressor (N-CoR) was not affected by the AR F826L mutation. The observed properties of AR F826L would be in agreement with an increased activity rather than with a partial defective AR transcriptional activation. It is concluded that the penoscrotal hypospadias in the present case is caused by an as yet unknown mechanism, which still may involve the mutant AR. </description>
    </item> <item>
      <title>Xist RNA is confined to the nuclear territory of the silenced X chromosome throughout the cell cycle (Article)</title>
      <link>http://repub.eur.nl/res/pub/15202/</link>
      <pubDate>2008-09-01T00:00:00Z</pubDate>
      <description>In mammalian female cells, one X chromosome is inactivated to prevent a dose difference in the expression of X-encoded proteins between males and females. Xist RNA, required for X chromosome inactivation, is transcribed from the future inactivated X chromosome (Xi), where it spreads in cis, to initiate silencing. We have analyzed Xist RNA transcription and localization throughout the cell cycle. It was found that Xist transcription is constant and that the mature RNA remains attached to the Xi throughout mitosis. Diploid and tetraploid cell lines with an MS2-tagged Xist gene were used to investigate spreading of Xist. Most XXXXMS2 tetraploid mouse embryonic stem (ES) cells inactivate the XMS2 chromosome and one other X chromosome. Analysis of cells with two Xi's indicates that Xist RNA is retained by the Xi of its origin and does not spread in trans. Also, in XXMS2 diploid mouse ES cells with an autosomal Xist transgene, there is no trans exchange of Xist RNA from the Xi to the autosome. We propose that Xist RNA does not dissociate from the Xi of its origin, which precludes a model of diffusion-mediated trans spreading of Xist RNA.</description>
    </item> <item>
      <title>Increased frequency of asynapsis and associated meiotic silencing of heterologous chromatin in the presence of irradiation-induced extra DNA double strand breaks (Article)</title>
      <link>http://repub.eur.nl/res/pub/29081/</link>
      <pubDate>2008-05-01T00:00:00Z</pubDate>
      <description>In meiotic prophase of male placental mammals, the heterologous X and Y chromosomes remain largely unsynapsed, which activates meiotic sex chromosome inactivation (MSCI), leading to formation of the transcriptionally silenced XY body. MSCI is most likely related to meiotic silencing of unsynapsed chromatin (MSUC), a mechanism that can silence autosomal unsynapsed chromatin. However, heterologous synapsis and escape from silencing also occur. In mammalian species, formation of DNA double strand breaks (DSBs) during leptotene precedes meiotic chromosome pairing. These DSBs are essential to achieve full synapsis of homologous chromosomes. We generated 25% extra meiotic DSBs by whole body irradiation of mice. This leads to a significant increase in meiotic recombination frequency. In mice carrying translocation chromosomes with synaptic problems, we observed an approximately 35% increase in asynapsis and MSUC of the nonhomologous region in the smallest chromosome pair following irradiation. However, the same nonhomologous region in the largest chromosome pair, shows complete synapsis and escape from MSUC in almost 100% of the nuclei, irrespective of exposure to irradiation. We propose that prevention of synapsis and associated activation of MSUC is linked to the presence of unrepaired meiotic DSBs in the nonhomologous region. Also, spreading of synaptonemal complex formation from regions of homology may act as an opposing force, and drive heterologous synapsis. </description>
    </item> <item>
      <title>Increased phosphorylation and dimethylation of XY body histones in the Hr6b-knockout mouse is associated with derepression of the X chromosome (Article)</title>
      <link>http://repub.eur.nl/res/pub/31785/</link>
      <pubDate>2007-06-01T00:00:00Z</pubDate>
      <description>Mono-ubiquitylated H2A marks the transcriptionally silenced XY body during male meiotic prophase. Concomitant with H2AK119ub1, the ubiquitin-conjugating enzyme HR6B is also enriched on the XY body. We analyzed H2A and H2B ubiquitylation in Hr6b-knockout mouse spermatocytes, but no global changes were detected. Next, we analyzed phosphorylation of the threonine residues T120 and T119 that are adjacent to the K119 and K120 target sites for ubiquitylation in H2A and H2B, respectively. In wild-type cells, H2AT120phand H2BT119phmark meiotically impaired and silenced chromatin, including the XY body. In Hr6b-knockout spermatocytes, the H2BT119phsignal was unchanged, but H2AT120phwas enhanced from late pachytene until metaphase I. Furthermore, we found increased H3K4dimethylation on the X and Y chromosomes of diplotene Hr6b-knockout spermatocytes, persisting into postmeiotic round spermatids. In these cells, the X and Y chromosomes maintained an unchanged H3K9m2level, even when this modification was lost from centromeric heterochromatin. Analysis of gene expression showed derepression of X chromosome genes in postmeiotic Hr6b-knockout spermatids. We conclude that HR6B exerts control over different histone modifications in spermatocytes and spermatids, and that this function contributes to the postmeiotic maintenance of X chromosome silencing.</description>
    </item> <item>
      <title>Differential contributions of mammalian Rad54 paralogs to recombination, DNA damage repair, and meiosis. (Article)</title>
      <link>http://repub.eur.nl/res/pub/13976/</link>
      <pubDate>2006-02-01T00:00:00Z</pubDate>
      <description>Homologous recombination is a versatile DNA damage repair pathway requiring Rad51 and Rad54. Here we show that a mammalian Rad54 paralog, Rad54B, displays physical and functional interactions with Rad51 and DNA that are similar to those of Rad54. While ablation of Rad54 in mouse embryonic stem (ES) cells leads to a mild reduction in homologous recombination efficiency, the absence of Rad54B has little effect. However, the absence of both Rad54 and Rad54B dramatically reduces homologous recombination efficiency. Furthermore, we show that Rad54B protects ES cells from ionizing radiation and the interstrand DNA cross-linking agent mitomycin C. Interestingly, at the ES cell level the paralogs do not display an additive or synergic interaction with respect to mitomycin C sensitivity, yet animals lacking both Rad54 and Rad54B are dramatically sensitized to mitomycin C compared to either single mutant. This suggests that the paralogs possibly function in a tissue-specific manner. Finally, we show that Rad54, but not Rad54B, is needed for a normal distribution of Rad51 on meiotic chromosomes. Thus, even though the paralogs have similar biochemical properties, genetic analysis in mice uncovered their nonoverlapping roles.</description>
    </item> <item>
      <title>The microtubule plus-end-tracking protein CLIP-170 associates with the spermatid manchette and is essential for spermatogenesis. (Article)</title>
      <link>http://repub.eur.nl/res/pub/13948/</link>
      <pubDate>2005-10-15T00:00:00Z</pubDate>
      <description>CLIP-170 is a microtubule "plus-end-tracking protein" implicated in the control of microtubule dynamics, dynactin localization, and the linking of endosomes to microtubules. To investigate the function of mouse CLIP-170, we generated CLIP-170 knockout and GFP-CLIP-170 knock-in alleles. Residual CLIP-170 is detected in lungs and embryos of homozygous CLIP-170 knockout mice, but not in other tissues and cell types, indicating that we have generated a hypomorphic mutant. Homozygous CLIP-170 knockout mice are viable and appear normal. However, male knockout mice are subfertile and produce sperm with abnormal heads. Using the knock-in mice, we followed GFP-CLIP-170 expression and behavior in dissected, live testis tubules. We detect plus-end-tracking GFP-CLIP-170 in spermatogonia. As spermatogenesis proceeds, GFP-CLIP-170 expression increases and the fusion protein strongly marks syncytia of differentiated spermatogonia and early prophase spermatocytes. Subsequently GFP-CLIP-170 levels drop, but during spermiogenesis (post-meiotic development), GFP-CLIP-170 accumulates again and is present on spermatid manchettes and centrosomes. Bleaching studies show that, as spermatogenesis progresses, GFP-CLIP-170 converts from a mobile plus-end-tracking protein to a relatively immobile protein. We propose that CLIP-170 has a structural function in the male germline, in particular in spermatid differentiation and sperm head shaping.</description>
    </item> <item>
      <title>Hedgehog signaling in mouse ovary: Indian hedgehog and desert hedgehog from granulosa cells induce target gene expression in developing theca cells. (Article)</title>
      <link>http://repub.eur.nl/res/pub/13801/</link>
      <pubDate>2005-08-01T00:00:00Z</pubDate>
      <description>Follicle development in the mammalian ovary requires interactions among the oocyte, granulosa cells, and theca cells, coordinating gametogenesis and steroidogenesis. Here we show that granulosa cells of growing follicles in mouse ovary act as a source of hedgehog signaling. Expression of Indian hedgehog and desert hedgehog mRNAs initiates in granulosa cells at the primary follicle stage, and we find induced expression of the hedgehog target genes Ptch1 and Gli1, in the surrounding pre-theca cell compartment. Cyclopamine, a highly specific hedgehog signaling antagonist, inhibits this induced expression of target genes in cultured neonatal mouse ovaries. The theca cell compartment remains a target of hedgehog signaling throughout follicle development, showing induced expression of the hedgehog target genes Ptch1, Ptch2, Hip1, and Gli1. In periovulatory follicles, a dynamic synchrony between loss of hedgehog expression and loss of induced target gene expression is observed. Oocytes are unable to respond to hedgehog because they lack expression of the essential signal transducer Smo (smoothened). The present results point to a prominent role of hedgehog signaling in the communication between granulosa cells and developing theca cells.</description>
    </item> <item>
      <title>Differences in invasive capacity of endometrial cancer cell lines expressing different progesterone receptor isotypes: possible involvement of cadherins (Article)</title>
      <link>http://repub.eur.nl/res/pub/15102/</link>
      <pubDate>2005-05-01T00:00:00Z</pubDate>
      <description>OBJECTIVE: Loss of expression of progesterone receptors (PR) in endometrial cancer is related to a more invasive and metastatic phenotype. In this study we aim to investigate whether selective loss of PRA or PRB affects the invasive capacity of endometrial cancer cells. METHODS: cDNA microarrays were performed to compare gene expression profiles of a set of endometrial cancer sub-cell lines expressing PRA and/or PRB. In vitro invasion assays were performed to assess whether differences in gene expression between the lines were reflected by their invasive behavior. RESULTS: It was observed that cell lines that express only PRA express higher levels of cadherins, and show a lower level of invasion compared to cell lines that express PRB. When cadherin function was inhibited in exclusively PRA-expressing cell lines, an increase of in vitro invasion was observed. In support of these findings, it was observed that in higher grade and more invasive endometrial cancer, expression of E-cadherin decreased. CONCLUSIONS: These results indicate that relative loss of PRA during progression of endometrial cancer can have a negative impact on cadherin expression, which may lead to development of a more metastatic phenotype.</description>
    </item> <item>
      <title>Expression profiling of androgen-dependent and -independent LNCaP cells: EGF versus androgen signalling. (Article)</title>
      <link>http://repub.eur.nl/res/pub/13730/</link>
      <pubDate>2005-03-01T00:00:00Z</pubDate>
      <description>Prostate cancer development often includes a shift from androgen-dependent to androgen-independent growth. It is hypothesized that, during this transition, growth factors like the epidermal growth factor (EGF) gain importance as activators of tumour cell proliferation. To study this, androgen- and EGF-regulation of growth and gene-expression was analysed in the androgen-dependent human prostate cancer cell line LNCaP-FGC (FGC) and its androgen-independent derivative line LNCaP-LNO (LNO). It was observed that androgen-dependent FGC cells require exposure to either androgens or EGF to proliferate. This is in contrast to androgen-independent LNO cells that showed significant proliferation in medium depleted of androgens and growth factors. Gene expression data were obtained for the androgen-dependent FGC and androgen-independent LNO cells cultured in the presence or absence of androgens (synthetic R1881) or EGF for different time periods. Expression profiling showed that many cell cycle genes, including a number of androgen- and EGF-regulated genes, are constitutively activated in androgen-independent LNO cells. Furthermore, the overlap between changes in gene expression activated by androgen and EGF receptor signalling pathways was found to be very high (75%). These results partly explain why androgen-independent LNO cells can proliferate in the absence of androgenic stimulation. However, possibly other, so far unknown, signal transduction pathways that induce and maintain proliferation, have also been activated.</description>
    </item> <item>
      <title>Silencing of unpaired chromatin and histone H2A ubiquitination in mammalian meiosis. (Article)</title>
      <link>http://repub.eur.nl/res/pub/13646/</link>
      <pubDate>2005-02-01T00:00:00Z</pubDate>
      <description>During meiotic prophase in male mammals, the X and Y chromosomes are incorporated in the XY body. This heterochromatic body is transcriptionally silenced and marked by increased ubiquitination of histone H2A. This led us to investigate the relationship between histone H2A ubiquitination and chromatin silencing in more detail. First, we found that ubiquitinated H2A also marks the silenced X chromosome of the Barr body in female somatic cells. Next, we studied a possible relationship between H2A ubiquitination, chromatin silencing, and unpaired chromatin in meiotic prophase. The mouse models used carry an unpaired autosomal region in male meiosis or unpaired X and Y chromosomes in female meiosis. We show that ubiquitinated histone H2A is associated with transcriptional silencing of large chromatin regions. This silencing in mammalian meiotic prophase cells concerns unpaired chromatin regions and resembles a phenomenon described for the fungus Neurospora crassa and named meiotic silencing by unpaired DNA.</description>
    </item> <item>
      <title>Functional analysis of a novel androgen receptor mutation, Q902K, in an individual with partial androgen insensitivity. (Article)</title>
      <link>http://repub.eur.nl/res/pub/13522/</link>
      <pubDate>2005-01-01T00:00:00Z</pubDate>
      <description>Androgen insensitivity syndrome (AIS) is caused by defects in the androgen
      receptor (AR) that render the AR partially or completely inactive. As a
      result, embryonic sex differentiation is impaired. Here, we describe a
      novel mutation in the AR found in a patient with partial AIS. The mutation
      results in a substitution of a glutamine (Q) by a lysine (K) residue at
      position 902, Q902K. The AR Q902K mutation was investigated in vitro with
      respect to its functional properties. The equilibrium dissociation
      constants (K(d)s) of AR Q902K in the presence of either the synthetic
      androgen R1881 or the natural ligand DHT were slightly elevated. The R1881
      dissociation rate (t(1/2)) was increased 3-fold for AR Q902K compared with
      wild type. Transcriptional activity was decreased to 85% of wild type, and
      the dose-response curve revealed that the sensitivity to hormone was
      decreased due to the mutation. Furthermore, the 114-kDa androgen-induced
      phosphorylated AR protein band was not detectable in genital skin
      fibroblasts. However, it could be detected in transfected CHO cells
      expressing the mutant receptor in the presence of 10 and 100 nm R1881.
      Functional interaction assays and a GST pull-down assay showed that the
      interaction between the NH2 and COOH terminus of AR Q902K was reduced to
      50% of wild type. Furthermore, the transactivation by the coactivator TIF2
      (transcriptional intermediary factor 2) was decreased 2- to 3-fold. The
      half-maximal response in both assays was shifted to a higher hormone
      concentration compared with wild type. These results indicate that residue
      Q902 is involved in TIF2 and NH2/COOH interaction and that the Q to K
      mutation results in a mild impairment of AR function, which can explain
      the partial AIS phenotype of the patient.</description>
    </item> <item>
      <title>Basic helix-loop-helix transcription factor Tcfl5 interacts with the Calmegin gene promoter in mouse spermatogenesis. (Article)</title>
      <link>http://repub.eur.nl/res/pub/13595/</link>
      <pubDate>2004-12-01T00:00:00Z</pubDate>
      <description>In mouse spermatogenesis, differentiating germ line cells initiate
      expression of specific genes at subsequent developmental steps. The
      Calmegin (Clgn) gene is first expressed in meiotic prophase, in primary
      spermatocytes, and encodes a protein that acts as a chaperone. To identify
      testis-specific transcription factors that control expression of the Clgn
      gene in spermatogenesis, we performed a yeast one-hybrid screening with a
      Clgn promoter sequence as bait DNA. This screening resulted in the
      identification of mouse Tcfl5 as a candidate Clgn promoter-binding
      protein. Tcfl5 is a member of the basic helix-loop-helix (bHLH) family of
      transcription factors, and mouse Tcfl5 shows 83% amino acid sequence
      identity with human TCFL5. Gel-shift and yeast one-hybrid experiments
      showed that Tcfl5 interacts with a non-canonical CACGCG site that is
      present in the Clgn promoter. By using northern blot, RT-PCR and in situ
      hybridization, mouse Tcfl5 mRNA was detected only in testis, with the
      highest expression level in primary spermatocytes and round spermatids.
      The highest level of Tcfl5 protein was found in primary spermatocytes at
      the diplotene stage of meiotic prophase, where the protein colocalizes
      with transcriptionally active chromatin.</description>
    </item> <item>
      <title>Phosphorylation of androgen receptor isoforms (Article)</title>
      <link>http://repub.eur.nl/res/pub/13437/</link>
      <pubDate>2004-10-15T00:00:00Z</pubDate>
      <description>Phosphorylation of the human AR (androgen receptor) is directly correlated with the appearance of at least three AR isoforms on an SDS/polyacrylamide gel. However, it is still not clear to what extent phosphorylation is involved in the occurrence of isoforms, which sites are phosphorylated and what are the functions of these phosphosites. The human AR was expressed in COS-1 cells and AR phosphorylation was studied further by mutational analyses and by using reversed-phase HPLC and MS. The reversed-phase HPLC elution pattern of the three isoforms revealed that Ser-650 was phosphorylated constitutively. After de novo synthesis, only Ser-650 was phosphorylated in the smallest isoform of 110 kDa and both Ser-650 and Ser-94 were phosphorylated in the second isoform of 112 kDa. The hormone-induced 114 kDa isoform shows an overall increase in phosphorylation of all the isolated peptides. The activities of the Ser-Ala substitution mutant S650A (Ser-650--&gt;Ala) was found to be identical with wild-type AR activation in four different cell lines and three different functional analyses, e.g. transactivation, N- and C-terminal-domain interaction and co-activation by transcriptional intermediary factor 2. This was also found for mutants S94A and S515A with respect to transactivation. However, the S515A mutation, which should eliminate phosphorylation of the potential mitogen-activated protein kinase site, Ser-515, resulted in an unphosphorylated form of the peptide containing Ser-650. This suggests that Ser-515 can modulate phosphorylation at another site. The present study shows that the AR isoform pattern from AR de novo synthesis is directly linked to differential phosphorylation of a distinct set of sites. After mutagenesis of these sites, no major change in functional activity of the AR was observed.</description>
    </item> <item>
      <title>The ubiquitin-conjugating DNA repair enzyme HR6A is a maternal factor essential for early embryonic development in mice. (Article)</title>
      <link>http://repub.eur.nl/res/pub/13407/</link>
      <pubDate>2004-06-01T00:00:00Z</pubDate>
      <description>The Saccharomyces cerevisiae RAD6 protein is required for a surprising diversity of cellular processes, including sporulation and replicational damage bypass of DNA lesions. In mammals, two RAD6-related genes, HR6A and HR6B, encode highly homologous proteins. Here, we describe the phenotype of cells and mice deficient for the mHR6A gene. Just like mHR6B knockout mouse embryonic fibroblasts, mHR6A-deficient cells appear to have normal DNA damage resistance properties, but mHR6A knockout male and female mice display a small decrease in body weight. The necessity for at least one functional mHR6A (X-chromosomal) or mHR6B (autosomal) allele in all somatic cell types is supported by the fact that neither animals lacking both proteins nor females with only one intact mHR6A allele are viable. In striking contrast to mHR6B knockout males, which show a severe spermatogenic defect, mHR6A knockout males are normally fertile. However, mHR6A knockout females fail to produce offspring despite a normal ovarian histology and ovulation. The absence of mHR6A in oocytes prevents development beyond the embryonic two-cell stage but does not result in an aberrant methylation pattern of histone H3 at this early stage of mouse embryonic development. These observations support redundant but dose-dependent roles for HR6A and HR6B in somatic cell types and germ line cells in mammals.</description>
    </item> <item>
      <title>Ubiquitin ligase Rad18Sc localizes to the XY body and to other chromosomal regions that are unpaired and transcriptionally silenced during male meiotic prophase (Article)</title>
      <link>http://repub.eur.nl/res/pub/8366/</link>
      <pubDate>2004-01-01T00:00:00Z</pubDate>
      <description>In replicative damage bypass (RDB) in yeast, the ubiquitin-conjugating enzyme RAD6 interacts with the ubiquitin ligase RAD18. In the mouse, these enzymes are represented by two homologs of RAD6, HR6a and HR6b, and one homolog of RAD18, Rad18Sc. Expression of these genes and the encoded proteins is ubiquitous, but there is relatively high expression in the testis. We have studied the subcellular localization by immunostaining Rad18Sc and other RDB proteins in mouse primary spermatocytes passing through meiotic prophase in spermatogenesis. The highest Rad18Sc protein level is found at pachytene and diplotene, and the protein localizes mainly to the XY body, a subnuclear region that contains the transcriptionally inactivated X and Y chromosomes. In spermatocytes that carry translocations for chromosomes 1 and 13, Rad18Sc protein concentrates on translocation bivalents that are not fully synapsed. The partly synapsed bivalents are often localized in the vicinity of the XY body, and show a very low level of RNA polymerase II, indicating that the chromatin is in a silent configuration similar to transcriptional silencing of the XY body. Thus, Rad18Sc localizes to unsynapsed and silenced chromosome segments during the male meiotic prophase. All known functions of RAD18 in yeast are related to RDB. However, in contrast to Rad18Sc, expression of UBC13 and poleta, known to be involved in subsequent steps of RDB, appears to be diminished in the XY body and regions containing the unpaired translocation bivalents. Taken together, these observations suggest that the observed subnuclear localization of Rad18Sc may involve a function outside the context of RDB. This function is probably related to a mechanism that signals the presence of unsynapsed chromosomal regions and subsequently leads to transcriptional silencing of these regions during male meiotic prophase.</description>
    </item> <item>
      <title>The ubiquitin-conjugating DNA repair enzyme is a maternal factor essential for early embryonic development in mice (Article)</title>
      <link>http://repub.eur.nl/res/pub/3221/</link>
      <pubDate>2004-01-01T00:00:00Z</pubDate>
      <description>The Saccharomyces cerevisiae RAD6 protein is required for a surprising diversity of cellular processes, including sporulation and replicational damage bypass of DNA lesions. In mammals, two RAD6-related genes, HR6A and HR6B, encode highly homologous proteins. Here, we describe the phenotype of cells and mice deficient for the mHR6A gene. Just like mHR6B knockout mouse embryonic fibroblasts, mHR6A-deficient cells appear to have normal DNA damage resistance properties, but mHR6A knockout male and female mice display a small decrease in body weight. The necessity for at least one functional mHR6A (X-chromosomal) or mHR6B (autosomal) allele in all somatic cell types is supported by the fact that neither animals lacking both proteins nor females with only one intact mHR6A allele are viable. In striking contrast to mHR6B knockout males, which show a severe spermatogenic defect, mHR6A knockout males are normally fertile. However, mHR6A knockout females fail to produce offspring despite a normal ovarian histology and ovulation. The absence of mHR6A in oocytes prevents development beyond the embryonic two-cell stage but does not result in an aberrant methylation pattern of histone H3 at this early stage of mouse embryonic development. These observations support redundant but dose-dependent roles for HR6A and HR6B in somatic cell types and germ line cells in mammals.</description>
    </item> <item>
      <title>Proteomic profiling of epididymis and vas deferens: identification of proteins regulated during rat genital tract development. (Article)</title>
      <link>http://repub.eur.nl/res/pub/13198/</link>
      <pubDate>2003-10-01T00:00:00Z</pubDate>
      <description>Epididymis and vas deferens form part of the male internal genital tract
      and are dependent on androgens for their growth and development. To better
      understand the molecular action of androgens during male genital tract
      development, protein expression profiles were generated using
      two-dimensional gels, for rat epididymides and vasa deferentia isolated on
      embryonic days (E) 17-21. Proteins that were differentially expressed
      between E17 and E21 were cut from the gels, digested into tryptic peptides
      and analyzed on a matrix-assisted laser desorption/ionization
      time-of-flight mass spectrometer. Using this approach, 20 proteins could
      be identified that were regulated in time and were categorized into
      cytoskeletal proteins, nuclear proteins, transport proteins, chaperones,
      and enzymes (mainly glycolytic). Furthermore, epididymides and vasa
      deferentia isolated on E19 were cultured in vitro in the absence or
      presence of 10 nm of the synthetic androgen R1881, for 9, 24, and 48 h.
      Under these conditions, regulation and posttranslational modification were
      observed for glyceraldehyde 3-phosphate dehydrogenase, triosephosphate
      isomerase, heterogeneous nuclear ribonucleoprotein A2/B1 and heterogeneous
      nuclear ribonucleoprotein A3, similar to the observed changes in vivo. In
      addition, posttranslational modification of RhoGDI1 (also named
      RhoGDIalpha) was found in response to androgen. Androgen-induced
      posttranslational modification of RhoGDI1 and glycolytic enzymes may be an
      important functional link between signaling pathways and cytoskeletal
      rearrangements in control of growth and development of the male internal
      genital tract.</description>
    </item> <item>
      <title>Proteomic analysis of androgen-regulated protein expression in a mouse fetal vas deferens cell line (Article)</title>
      <link>http://repub.eur.nl/res/pub/31830/</link>
      <pubDate>2003-04-01T00:00:00Z</pubDate>
      <description>During sex differentiation, androgens are essential for development of the male genital tract. The Wolffian duct is an androgen-sensitive target tissue that develops into the epididymis, vas deferens, and seminal vesicle. The present study aimed to identify androgen-regulated proteins that are involved in development of Wolffian duct-derived structures. We have used male mouse embryos transgenic for temperature-sensitive simian virus 40 large tumor antigen at 18 d of gestation, to generate immortalized mouse fetal vas deferens (MFVD) parental and clonal cell lines. The MFVD parental and clonal cell lines express androgen receptor protein and show features of Wolffian duct mesenchymal cells. Clonal cell line MFVD A6 was selected for proteomic analysis and cultured in the absence or presence of androgens. Subsequently, two-dimensional gel electrophoresis was performed on total cell lysates. Differentially expressed proteins were analyzed by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry and two androgen-regulated proteins were identified as mElfin and CArG-binding factor-A (CBF-A). CBF-A and mElfin are known to bind to cytoskeletal F-actin. Both proteins appeared to be regulated by androgens at the posttranslational level, possibly involving phosphorylation. Posttranslational modification of mElfin and CBF-A by androgens may be associated with a cytoskeletal change that is involved in androgen-regulated gene expression.</description>
    </item> <item>
      <title>Loss of HR6B ubiquitin-conjugating activity results in damaged synaptonemal complex structure and increased crossing-over frequency during the male meiotic prophase (Article)</title>
      <link>http://repub.eur.nl/res/pub/10083/</link>
      <pubDate>2003-01-01T00:00:00Z</pubDate>
      <description>The ubiquitin-conjugating enzymes HR6A and HR6B are the two mammalian homologs of Saccharomyces cerevisiae RAD6. In yeast, RAD6 plays an important role in postreplication DNA repair and in sporulation. HR6B knockout mice are viable, but spermatogenesis is markedly affected during postmeiotic steps, leading to male infertility. In the present study, increased apoptosis of HR6B knockout primary spermatocytes was detected during the first wave of spermatogenesis, indicating that HR6B performs a primary role during the meiotic prophase. Detailed analysis of HR6B knockout pachytene nuclei showed major changes in the synaptonemal complexes. These complexes were found to be longer. In addition, we often found depletion of synaptonemal complex proteins from near telomeric regions in the HR6B knockout pachytene nuclei. Finally, we detected an increased number of foci containing the mismatch DNA repair protein MLH1 in these nuclei, reflecting a remarkable and consistent increase (20 to 25%) in crossing-over frequency. The present findings reveal a specific requirement for the ubiquitin-conjugating activity of HR6B in relation to dynamic aspects of the synaptonemal complex and meiotic recombination in spermatocytes</description>
    </item> <item>
      <title>Proteomic analysis of androgen-regulated protein expression in a mouse fetal vas deferens cell line (Article)</title>
      <link>http://repub.eur.nl/res/pub/10113/</link>
      <pubDate>2003-01-01T00:00:00Z</pubDate>
      <description>During sex differentiation, androgens are essential for development of the
      male genital tract. The Wolffian duct is an androgen-sensitive target
      tissue that develops into the epididymis, vas deferens, and seminal
      vesicle. The present study aimed to identify androgen-regulated proteins
      that are involved in development of Wolffian duct-derived structures. We
      have used male mouse embryos transgenic for temperature-sensitive simian
      virus 40 large tumor antigen at 18 d of gestation, to generate
      immortalized mouse fetal vas deferens (MFVD) parental and clonal cell
      lines. The MFVD parental and clonal cell lines express androgen receptor
      protein and show features of Wolffian duct mesenchymal cells. Clonal cell
      line MFVD A6 was selected for proteomic analysis and cultured in the
      absence or presence of androgens. Subsequently, two-dimensional gel
      electrophoresis was performed on total cell lysates. Differentially
      expressed proteins were analyzed by matrix-assisted laser
      desorption/ionization time-of-flight mass spectrometry and two
      androgen-regulated proteins were identified as mElfin and CArG-binding
      factor-A (CBF-A). CBF-A and mElfin are known to bind to cytoskeletal
      F-actin. Both proteins appeared to be regulated by androgens at the
      posttranslational level, possibly involving phosphorylation.
      Posttranslational modification of mElfin and CBF-A by androgens may be
      associated with a cytoskeletal change that is involved in
      androgen-regulated gene expression.</description>
    </item> <item>
      <title>Progestogenic effects of tibolone on human endometrial cancer cells (Article)</title>
      <link>http://repub.eur.nl/res/pub/10130/</link>
      <pubDate>2003-01-01T00:00:00Z</pubDate>
      <description>Tibolone, a synthetic steroid acting in a tissue-specific manner and used
      in hormone replacement therapy, is converted into three active
      metabolites: a Delta(4) isomer (exerting progestogenic and androgenic
      effects) and two hydroxy metabolites, 3 alpha-hydroxytibolone (3
      alpha-OH-tibolone) and 3beta-OH-tibolone (exerting estrogenic effects). In
      the present study an endometrial carcinoma cell line (Ishikawa PRAB-36)
      was used to investigate the progestogenic properties of tibolone and its
      metabolites. This cell line contains progesterone receptors A and B, but
      lacks estrogen and androgen receptors. When tibolone was added to the
      cells, complete conversion into the progestogenic/androgenic Delta(4)
      isomer was observed within 6 d. Furthermore, when cells were cultured with
      tibolone or when the Delta(4) isomer or the established progestagen
      medroxyprogesterone acetate was added to the medium, marked inhibition of
      growth was observed. Interestingly, 3 beta-OH-tibolone also induces some
      inhibition of growth. These growth inhibitions were not observed in
      progesterone receptor-negative parental Ishikawa cells, and
      progestagen-induced growth inhibition of PRAB-36 cells could readily be
      reversed using the antiprogestagen Org-31489. Upon measuring the
      expression of two progesterone-regulated genes (fibronectin and
      IGF-binding protein-3), tibolone, the Delta(4) isomer and
      medroxyprogesterone acetate showed similar gene expression regulation.
      These results indicate that tibolone, the Delta(4) metabolite, and to some
      extent 3 beta-OH-tibolone exert progestogenic effects. Tibolone and most
      likely 3 beta-OH-tibolone are converted into the Delta(4) metabolite.</description>
    </item> <item>
      <title>Consequences of loss of progesterone receptor expression in development of invasive endometrial cancer (Article)</title>
      <link>http://repub.eur.nl/res/pub/10230/</link>
      <pubDate>2003-01-01T00:00:00Z</pubDate>
      <description>PURPOSE: In endometrial cancer, loss of progesterone receptors (PR) is
      associated with more advanced disease. This study aimed to investigate the
      mechanism of action of progesterone and the loss of its receptors (PRA and
      PRB) in development of endometrial cancer. EXPERIMENTAL DESIGN: A
      9600-cDNA microarray analysis was performed to study regulation of gene
      expression in the human endometrial cancer subcell line Ishikawa PRAB-36
      by the progestagen medroxy progesterone acetate (MPA). Five MPA-regulated
      genes were selected for additional investigation. Expression of these
      genes was studied by Northern blot and by immunohistochemistry in Ishikawa
      subcell lines expressing different PR isoforms. Additionally, endometrial
      cancer tissue samples were immunohistochemically stained to study the in
      vivo protein expression of the selected genes. RESULTS: In the PRAB-36
      cell line, MPA was found to regulate the expression of a number of
      invasion- and metastasis-related genes. On additional investigation of
      five of these genes (CD44, CSPG/Versican, Tenascin-C, Fibronectin-1, and
      Integrin-beta 1), it was observed that expression and progesterone
      regulation of expression of these genes varied in subcell lines expressing
      different PR isoforms. Furthermore, in advanced endometrial cancer, it was
      shown that loss of expression of both PR and E-cadherin was associated
      with increased expression CD44 and CSPG/Versican. CONCLUSION: The present
      study shows that progestagens exert a modulatory effect on the expression
      of genes involved in tumor cell invasion. As a consequence, loss of PR
      expression in human endometrial cancer may lead to development of a more
      invasive phenotype of the respective tumor.</description>
    </item> <item>
      <title>Loss of HR6B ubiquitin-conjugating activity results in damaged synaptonemal complex structure and increased crossing-over frequency during the male meiotic prophase. (Article)</title>
      <link>http://repub.eur.nl/res/pub/3207/</link>
      <pubDate>2003-01-01T00:00:00Z</pubDate>
      <description>The ubiquitin-conjugating enzymes HR6A and HR6B are the two mammalian homologs of Saccharomyces cerevisiae RAD6. In yeast, RAD6 plays an important role in postreplication DNA repair and in sporulation. HR6B knockout mice are viable, but spermatogenesis is markedly affected during postmeiotic steps, leading to male infertility. In the present study, increased apoptosis of HR6B knockout primary spermatocytes was detected during the first wave of spermatogenesis, indicating that HR6B performs a primary role during the meiotic prophase. Detailed analysis of HR6B knockout pachytene nuclei showed major changes in the synaptonemal complexes. These complexes were found to be longer. In addition, we often found depletion of synaptonemal complex proteins from near telomeric regions in the HR6B knockout pachytene nuclei. Finally, we detected an increased number of foci containing the mismatch DNA repair protein MLH1 in these nuclei, reflecting a remarkable and consistent increase (20 to 25%) in crossing-over frequency. The present findings reveal a specific requirement for the ubiquitin-conjugating activity of HR6B in relation to dynamic aspects of the synaptonemal complex and meiotic recombination in spermatocytes.</description>
    </item> <item>
      <title>Developmental defects and male sterility in mice lacking the ubiquitin-like DNA repair gene mHR23B (Article)</title>
      <link>http://repub.eur.nl/res/pub/31840/</link>
      <pubDate>2002-02-05T00:00:00Z</pubDate>
      <description>mHR23B encodes one of the two mammalian homologs of Saccharomyces cerevisiae RAD23, a ubiquitin-like fusion protein involved in nucleotide excision repair (NER). Part of mHR23B is complexed with the XPC protein, and this heterodimer functions as the main damage detector and initiator of global genome NER. While XPC defects exist in humans and mice, mutations for mHR23A and mHR23B are not known. Here, we present a mouse model for mHR23B. Unlike XPC-deficient cells, mHR23B-/-mouse embryonic fibroblasts are not UV sensitive and retain the repair characteristics of wild-type cells. In agreement with the results of in vitro repair studies, this indicates that mHR23A can functionally replace mHR23B in NER. Unexpectedly, mHR23B-/-mice show impaired embryonic development and a high rate (90%) of intrauterine or neonatal death. Surviving animals display a variety of abnormalities, including retarded growth, facial dysmorphology, and male sterility. Such abnormalities are not observed in XPC and other NER-deficient mouse mutants and point to a separate function of mHR23B in development. This function may involve regulation of protein stability via the ubiquitin/proteasome pathway and is not or only in part compensated for by mHR23A.</description>
    </item> <item>
      <title>Developmental defects and male sterility in mice lacking the ubiquitin-like DNA repair gene mHR23B. (Article)</title>
      <link>http://repub.eur.nl/res/pub/3193/</link>
      <pubDate>2002-01-01T00:00:00Z</pubDate>
      <description>mHR23B encodes one of the two mammalian homologs of Saccharomyces cerevisiae RAD23, a ubiquitin-like fusion protein involved in nucleotide excision repair (NER). Part of mHR23B is complexed with the XPC protein, and this heterodimer functions as the main damage detector and initiator of global genome NER. While XPC defects exist in humans and mice, mutations for mHR23A and mHR23B are not known. Here, we present a mouse model for mHR23B. Unlike XPC-deficient cells, mHR23B(-/-) mouse embryonic fibroblasts are not UV sensitive and retain the repair characteristics of wild-type cells. In agreement with the results of in vitro repair studies, this indicates that mHR23A can functionally replace mHR23B in NER. Unexpectedly, mHR23B(-/-) mice show impaired embryonic development and a high rate (90%) of intrauterine or neonatal death. Surviving animals display a variety of abnormalities, including retarded growth, facial dysmorphology, and male sterility. Such abnormalities are not observed in XPC and other NER-deficient mouse mutants and point to a separate function of mHR23B in development. This function may involve regulation of protein stability via the ubiquitin/proteasome pathway and is not or only in part compensated for by mHR23A.</description>
    </item> <item>
      <title>Anti-Mullerian hormone inhibits initiation of primordial follicle growth in the mouse ovary (Article)</title>
      <link>http://repub.eur.nl/res/pub/9858/</link>
      <pubDate>2002-01-01T00:00:00Z</pubDate>
      <description>Recruitment of primordial follicles is essential for female fertility;
      however, the exact mechanisms regulating this process are largely unknown.
      Earlier studies using anti-Mullerian hormone (AMH)-deficient mice
      suggested that AMH is involved in the regulation of primordial follicle
      recruitment. We tested this hypothesis in a neonatal ovary culture system,
      in which ovaries from 2-d-old C57Bl/6J mice were cultured for 2 or 4 d in
      the absence or presence of AMH. Ovaries from 2-d-old mice contain multiple
      primordial follicles, some naked oocytes, and no follicles at later stages
      of development. We observed that in the cultured ovaries, either
      nontreated or AMH-treated, follicular development progressed to the same
      extent as in in vivo ovaries of comparable age, confirming the validity of
      our culture system. However, in the presence of AMH, cultured ovaries
      contained 40% fewer growing follicles compared with control ovaries. A
      similar reduction was found after 4 d of culture. Consistent with these
      findings, we noted lower inhibin alpha-subunit expression in AMH-treated
      ovaries compared with untreated ovaries. In contrast, expression of AMH
      ligand type II receptor and the expression of oocyte markers growth and
      differentiation factor 9 and zona pellucida protein 3 were not influenced
      by AMH. Based on the results, we suggest that AMH inhibits initiation of
      primordial follicle growth and therefore functions as an inhibitory growth
      factor in the ovary during these early stages of folliculogenesis.</description>
    </item> <item>
      <title>DNA repair mechanisms and gametogenesis (Article)</title>
      <link>http://repub.eur.nl/res/pub/9599/</link>
      <pubDate>2001-01-01T00:00:00Z</pubDate>
      <description>In mammals, there is a complex and intriguing relationship between DNA
          repair and gametogenesis. DNA repair mechanisms are involved not only in
          the repair of different types of DNA damage in developing germline cells,
          but also take part in the meiotic recombination process. Furthermore, the
          DNA repair mechanisms should tolerate mutations occurring during
          gametogenesis, to a limited extent. In the present review, several
          gametogenic aspects of DNA mismatch repair, homologous recombination
          repair and postreplication repair are discussed. In addition, the role of
          DNA damage-induced cell cycle checkpoint control is considered briefly. It
          appears that many genes encoding proteins that take part in DNA repair
          mechanisms show enhanced or specialized expression during mammalian
          gametogenesis, and several gene knockout mouse models show male or female
          infertility. On the basis of such knowledge and models, future experiments
          may provide more information about the precise relationship between DNA
          repair, chromatin dynamics, and genomic stability versus instability
          during gametogenesis.</description>
    </item> <item>
      <title>Anti-Mullerian hormone attenuates the effects of FSH on follicle development in the mouse ovary (Article)</title>
      <link>http://repub.eur.nl/res/pub/9773/</link>
      <pubDate>2001-01-01T00:00:00Z</pubDate>
      <description>Although ovarian follicle growth is under the influence of many growth
      factors and hormones of which FSH remains one of the most prominent
      regulators. Therefore, factors affecting the sensitivity of ovarian
      follicles to FSH are also important for follicle growth. The aim of the
      present study was to investigate whether anti-Mullerian hormone (AMH) has
      an inhibitory effect on follicle growth by decreasing the sensitivity of
      ovarian follicles to FSH. Furthermore, the combined action of AMH and FSH
      on ovarian follicle development was examined. Three different experiments
      were performed. Using an in vitro follicle culture system it was shown
      that FSH-stimulated preantral follicle growth is attenuated in the
      presence of AMH. This observation was confirmed by an in vivo experiment
      showing that in immature AMH-deficient females, more follicles start to
      grow under the influence of exogenous FSH than in their wild-type
      littermates. In a third experiment, examination of the follicle population
      of 4-month-old wild-type, FSH beta-, AMH-, and AMH-/FSH beta-deficient
      females revealed that loss of FSH expression has no impact on the number
      of primordial and preantral follicles, but the loss of inhibitory action
      of AMH on the recruitment of primordial follicles in AMH-deficient mice is
      increased in the absence of FSH. In conclusion, these studies show that
      AMH inhibits FSH-stimulated follicle growth in the mouse, suggesting that
      AMH is one of the factors determining the sensitivity of ovarian follicles
      for FSH and that AMH is a dominant regulator of early follicle growth.</description>
    </item> <item>
      <title>Characterization of mRAD18Sc, a mouse homolog of the yeast post-replication repair gene RAD18. (Article)</title>
      <link>http://repub.eur.nl/res/pub/3167/</link>
      <pubDate>2000-10-01T00:00:00Z</pubDate>
      <description>The RAD18 gene of the yeast Saccharomyces cerevisiae encodes a protein with ssDNA binding activity that interacts with the ubiquitin-conjugating enzyme RAD6 and plays an important role in postreplication repair. We identified and characterized the putative mouse homolog of RAD18, designated mRAD18Sc. The mRAD18Sc open reading frame encodes a 509-amino-acid polypeptide that is strongly conserved in size and sequence between yeast and mammals, with specific conservation of the RING-zinc-finger and the classic zinc-finger domain. The degree of sequence conservation between mRAD18Sc, RAD18, and homologous sequences identified in other species (NuvA from Aspergillus nidulans and Uvs-2 from Neurospora crassa) is entirely consistent with the evolutionary relationship of these organisms, strongly arguing that these genes are one another's homologs. Consistent with the presence of a nuclear translocation signal in the amino acid sequence, we observed the nuclear localization of GFP-tagged mRAD18Sc after stable transfection to HeLa cells. mRNA expression of mRAD18Sc in the mouse was observed in thymus, spleen, brain, and ovary, but was most pronounced in testis, with the highest level of expression in pachytene-stage primary spermatocytes, suggesting that mRAD18Sc plays a role in meiosis of spermatogenesis. Finally, we mapped the mRAD18Sc gene on mouse chromosome 6F.</description>
    </item> <item>
      <title>Involvement of insulin-like factor 3 (Insl3) in diethylstilbestrol-induced cryptorchidism (Article)</title>
      <link>http://repub.eur.nl/res/pub/9240/</link>
      <pubDate>2000-01-01T00:00:00Z</pubDate>
      <description>Recently, it has been shown that targeted inactivation of the Insl3 gene
          in male mice results in cryptorchidism. The Insl3 gene encodes
          insulin-like factor 3 (Insl3), which is expressed in fetal Leydig cells.
          The testicular factor Insl3 appears to play an important role in the
          transabdominal phase of testis descent, which involves development of the
          gubernaculum. Other studies have demonstrated that in utero exposure to
          diethylstilbestrol (DES), a synthetic estrogen, can lead to cryptorchidism
          both in humans and in animal models. The present study was undertaken to
          investigate whether prenatal DES-exposure might interfere with testicular
          Insl3 mRNA expression. Furthermore, the effect of DES on steroidogenic
          factor 1 (SF-1) mRNA expression level was determined, since it has been
          shown that SF-1 plays an essential role in transcriptional activation of
          the Insl3 gene promoter. Timed pregnant mice were treated with DES (100
          microg/kg body weight) or vehicle alone on days E9 (gestational day 9)
          through E17. Control and DES-exposed mouse fetuses were collected at E16,
          E17 and E18, when transabdominal testis descent is taking place. Lack of
          gubernaculum development in DES-exposed animals was confirmed by
          histological analyses at E17. Expression of Insl3 and SF-1 mRNAs was
          studied in testes of control and DES-exposed fetuses at E16 and E18 by
          RNase protection assay. Prenatal DES-exposure resulted in a three-fold
          decrease in Insl3 mRNA expression level (P&lt;0.005), at both E16 and E18. In
          contrast, DES treatment had no effect on the expression of SF-1 mRNA.
          These results support our hypothesis that DES may interfere with
          gubernaculum development by altering Insl3 mRNA expression, providing a
          possible mechanism by which DES may cause cryptorchidism.</description>
    </item> <item>
      <title>Apoptotic and proliferative changes during induced atresia of pre-ovulatory follicles in the rat (Article)</title>
      <link>http://repub.eur.nl/res/pub/9546/</link>
      <pubDate>2000-01-01T00:00:00Z</pubDate>
      <description>Atresia, a degenerative process through which many follicles are removed
          from the growing pool, involves apoptotic changes in the follicular
          granulosa cells. To identify histochemical markers of early stages of
          atresia, an in-vivo rat model was used which allowed the study of atresia
          of pre-ovulatory follicles in a synchronized and chronological order. By
          blocking the pre-ovulatory luteinizing hormone surge with a
          gonadotrophin-releasing hormone (GnRH) antagonist, ovulation of the
          pre-ovulatory follicles is prevented, after which these follicles became
          atretic. The first morphological sign of atresia (pyknotic granulosa cell
          nuclei) was found 27 h after injection of GnRH antagonist. Since the
          pre-ovulatory follicles gradually become atretic in a synchronous fashion,
          this model provided an opportunity to study and define markers of future
          atresia in pre-ovulatory follicles. Atresia involves apoptosis of
          granulosa cells, and therefore internucleosomal DNA fragmentation was
          examined. Using the terminal deoxynucleotidyltransferase-mediated
          dUTP-biotin nick end labelling (TUNEL) assay it was found that the first
          sign of internucleosomal DNA fragmentation in granulosa cells of
          pre-ovulatory follicles was detectable 24 h after GnRH antagonist
          treatment. In order to find an upstream marker of atresia, the
          5-bromo-deoxyuridine (BrdU) labelling index was used as a measure of
          proliferation. Already at 14 h after GnRH antagonist treatment, when
          morphological signs of atresia were not yet present, a clear decrease in
          BrdU labelling index was found in the granulosa cells.</description>
    </item> <item>
      <title>Hormonal control of gubernaculum development during testis descent: gubernaculum outgrowth in vitro requires both insulin-like factor and androgen (Article)</title>
      <link>http://repub.eur.nl/res/pub/9551/</link>
      <pubDate>2000-01-01T00:00:00Z</pubDate>
      <description>The gubernaculum connects the gonad to the inguinoscrotal region and is
          involved in testis descent. It rapidly develops in the male fetus, whereas
          development in the female fetus is lacking. Possible factors involved in
          gubernaculum development are androgens, anti-Mullerian hormone (AMH), and
          insulin-like factor (Insl3). Sexual dimorphism in gubernaculum development
          correlated with the mitotic activity of cells in the gubernacular bulbs
          from male and female fetuses. Androgen receptor expression was restricted
          to the mesenchymal core of the gubernacular bulb, whereas skeletal muscle
          was detected in its outer layer. In an organ culture system devised to
          further study gubernaculum development in vitro, morphology of
          gubernacular explants grown in the presence of testes was comparable with
          that of gubernacula developed in vivo. Testicular tissue or medium
          containing R1881, a synthetic androgen, had a growth stimulatory effect on
          gubernacular explants compared with ovarian tissue or basal medium only.
          Moreover, Amh-/-, Amh+/-, and Insl3+/- testes stimulated the growth of
          gubernacular explants to the same extent as control testes. Insl3-/-
          testes, however, did not produce such an activity. This study reveals an
          essential role for both androgen and Insl3 in the gubernaculum outgrowth
          during transabdominal testis descent.</description>
    </item> <item>
      <title>Control of primordial follicle recruitment by anti-Mullerian hormone in the mouse ovary (Article)</title>
      <link>http://repub.eur.nl/res/pub/9201/</link>
      <pubDate>1999-01-01T00:00:00Z</pubDate>
      <description>The dimeric glycoprotein anti-Mullerian hormone (AMH) is a member of the
          transforming growth factor-beta superfamily of growth and differentiation
          factors. During male fetal sex differentiation, AMH is produced by Sertoli
          cells and induces degeneration of the Mullerian ducts, which form the
          anlagen of part of the internal female genital system. In females, AMH is
          produced by the ovary, but only postnatally. The function of AMH in the
          ovary is, however, still unknown. Female AMH null mice were reported to be
          fertile, with normal litter size, but this does not exclude a more subtle
          function for ovarian AMH. To investigate the function of AMH in the ovary,
          the complete follicle population was determined in AMH null mice, in mice
          heterozygous for the AMH null mutation, and in wild-type mice of different
          ages: 25 days, 4 months, and 13 months. In the present study we found that
          ovaries of 25-day- and 4-month-old AMH null females, compared to those of
          wild-type females, contain more preantral and small antral follicles. In
          addition, in 4- and 13-month-old AMH null females, smaller numbers of
          primordial follicles were found. Actually, in 13-month-old AMH null
          females, almost no primordial follicles could be detected, coinciding with
          a reduced number of preantral and small antral follicles in these females.
          In almost all females heterozygous for the AMH null mutation the number of
          follicles fell in between the numbers found in wild-type and AMH null
          females. In 4-month-old AMH null females serum inhibin levels were higher
          and FSH levels were lower compared to those in wild-type females. In
          contrast, inhibin levels were lower in 13-month-old AMH null females, and
          FSH levels were unchanged compared to those in wild-type females.
          Furthermore, the weight of the ovaries was twice as high in the
          4-month-old AMH null females as in age-matched wild-type females. We
          conclude that AMH plays an important role in primordial follicle
          recruitment, such that more primordial follicles are recruited in AMH null
          mice than in wild-type mice; the mice heterozygous for the AMH null
          mutation take an in-between position. Consequently, the ovaries of AMH
          null females and those of females heterozygous for the AMH null mutation
          will show a relatively early depletion of their stock of primordial
          follicles. The female AMH null mouse may thus provide a useful model to
          study regulation of primordial follicle recruitment and the relation
          between follicular dynamics and ovarian aging.</description>
    </item> <item>
      <title>Macroorchidism in FMR1 knockout mice is caused by increased Sertoli cell proliferation during testicular development (Article)</title>
      <link>http://repub.eur.nl/res/pub/8756/</link>
      <pubDate>1998-01-01T00:00:00Z</pubDate>
      <description>The fragile X syndrome is the most frequent hereditary form of mental
          retardation. This X-linked disorder is, in most cases, caused by an
          unstable and expanding trinucleotide CGG repeat located in the
          5'-untranslated region of the gene involved, the fragile X mental
          retardation 1 (FMR1) gene. Expansion of the CGG repeat to a length of more
          than 200 trinucleotides results in silencing of the FMR1 gene promoter
          and, thus, in an inactive gene. The clinical features of male fragile X
          patients include mental retardation, autistiform behavior, and
          characteristic facial features. In addition, macroorchidism is observed.
          To study the role of Sertoli cell proliferation and FSH signal
          transduction in the occurrence of macroorchidism in fragile X males, we
          made use of an animal model for the fragile X syndrome, an Fmr1 knockout
          mouse. The results indicate that in male Fmr1 knockout mice, the rate of
          Sertoli cell proliferation is increased from embryonic day 12 to 15 days
          postnatally. The onset and length of the period of Sertoli cell
          proliferation were not changed compared with those in the control males.
          Serum levels of FSH, FSH receptor messenger RNA expression, and short term
          effects of FSH on Sertoli cell function, as measured by down-regulation of
          FSH receptor messenger RNA, were not changed. We conclude that
          macroorchidism in Fmr1 knockout male mice is caused by an increased rate
          of Sertoli cell proliferation. This increase does not appear to be the
          result of a major change in FSH signal transduction in Fmr1 knockout mice.</description>
    </item> <item>
      <title>Androgen action during male sex differentiation includes suppression of cranial suspensory ligament development (Article)</title>
      <link>http://repub.eur.nl/res/pub/8848/</link>
      <pubDate>1998-01-01T00:00:00Z</pubDate>
      <description>The cranial suspensory ligament is located on the border of the cranial
          (mesonephric) mesentery in adult female mammals, which runs between the
          cranial pole of the internal genitalia and the dorsal abdominal wall.
          Absence of the cranial suspensory ligament in male mammals depends upon
          exposure of its primordium to fetal testicular androgens and is a
          prerequisite for testis descent. Female rats were exposed to
          5alpha-dihydrotestosterone propionate at different stages of genital
          development, and cranial suspensory ligament development was studied in
          neonatal and in adult animals. Androgens suppressed cranial suspensory
          ligament development when exposure started during the early stages of
          genital development, until day 19 postconception (pc). Androgen receptor
          expression was immunohistochemically detected in the cranial mesentery of
          both sexes from day 16 pc onwards. A decrease of androgen receptor
          expression in female fetuses from day 18 pc onwards coincided with the
          appearance of a differentiated cranial suspensory ligament, as evidenced
          by the expression of two cell differentiation markers: alpha-smooth muscle
          (alpha-SM) actin and desmin. alpha-SM actin was located on the outer
          border of the cranial mesentery of both sexes at day 17 pc, and expression
          increased only in female fetuses. On day 19 pc, desmin expression was also
          detectable in the a-SM actin-positive cells. Proliferation and apoptosis
          indices of cells in the cranial mesentery, as analysed by
          5'-bromodeoxyuridine incorporation and by detection of DNA strand breaks
          (TUNEL method) respectively, did not show any difference between the
          sexes, neither on day 17 nor on day 18 pc. Since primordial cells of the
          cranial suspensory ligament highly express the androgen receptor during
          the period of gestation when androgens can suppress cranial suspensory
          development, altered morphogenesis of these cells may be a direct
          consequence of androgen action.</description>
    </item> <item>
      <title>Immunoexpression of testis-specific histone 2B in human spermatozoa and testis tissue (Article)</title>
      <link>http://repub.eur.nl/res/pub/8871/</link>
      <pubDate>1998-01-01T00:00:00Z</pubDate>
      <description>During mammalian spermatogenesis, the chromatin of the spermatogenic cells
          is profoundly reorganized. Somatic histones are partly replaced by
          testis-specific histones. These histones are then replaced by transition
          proteins and finally by protamines. This series of nucleoprotein
          rearrangements results in a highly condensed sperm cell nucleus. In
          contrast to spermatozoa from other species, human spermatozoa still
          contain a significant amount of histones, including testis-specific
          histone 2B (TH2B). In the present study it is shown that an antibody
          targeting tyrosine hydroxylase, which has been found previously to
          cross-react with rat TH2B, also specifically immunoreacts with human TH2B
          on Western blots, in immunohistochemistry of human testis tissue, and in
          immunocytochemistry of decondensed human spermatozoa. In human testis
          tissue, TH2B immunostaining first apparent in spermatogonia, shows marked
          variation, especially at the pachytene spermatocyte stage, and then
          reaches an intense signal in round spermatids. Shortly before spermatid
          elongation, a portion of the spermatid nucleus, corresponding to the
          acrosomal region, loses its immunoreactivity. During condensation of the
          spermatid nucleus, the immunodetectability of TH2B disappears gradually,
          from the anterior region of the nucleus onwards. At the final stages of
          spermiogenesis, the immunostaining is completely absent.
          Immunocytochemical staining of spermatozoa revealed no TH2B immunosignal,
          but immunostaining was observed when spermatozoa obtained from semen were
          decondensed to make nuclear proteins accessible to the antibody. There
          was, however, a striking intercellular variability in the intensity of
          staining of spermatozoa within an ejaculate. In a population of 35 men
          attending our Andrology Clinic, we observed interindividual differences in
          total sperm TH2B content, which showed a significant, although not very
          pronounced, negative correlation with normal morphology (P = 0.05).</description>
    </item> <item>
      <title>Differential regulation of leucine-rich primary response gene 1 (LRPR1) mRNA expression in rat testis and ovary (Article)</title>
      <link>http://repub.eur.nl/res/pub/8877/</link>
      <pubDate>1998-01-01T00:00:00Z</pubDate>
      <description>In immature rat Sertoli cells, leucine-rich primary response gene 1
          (LRPR1) represents a follicle stimulating hormone (FSH)-responsive gene;
          the function of the encoded protein is not yet known. LRPR1 mRNA
          expression is up-regulated very rapidly and specifically by FSH, both in
          cultured Sertoli cells and in vivo in regulation in more detail, in testis
          and ovary of fetal, immature, and adult rats. In addition, we have studied
          the expression of FSH receptor (FSHR) mRNA in relation to LRPR1 mRNA
          expression. In rat testis, LRPR1 mRNA and FSHR mRNA followed a similar
          expression pattern, during postnatal development and also at different
          stages of the spermatogenic cycle in the adult rat. Furthermore, after
          short-term challenge of the FSH signal transduction pathway in intact
          immature rats by injection with a relatively high dose of FSH, an inverse
          relationship between LRPR1 mRNA (up-regulation) and FSHR mRNA expression
          (down-regulation) was observed. Similar studies in the ovary provided
          completely different results. LRPR1 mRNA in the postnatal ovary is present
          well before expression of FSHR mRNA can be first detected. In addition,
          incubation of ovaries of immature rats with FSH or dibutyryl cyclic AMP
          (dbcAMP) did not result in up-regulation of LRPR1 mRNA expression. During
          fetal development, the LRPR1 mRNA expression pattern involved many more
          tissues, in contrast to the relatively tissue-specific expression of LRPR1
          mRNA in gonads of 21 day old and adult rats. Moreover, LRPR1 mRNA
          expression could be detected as early as 12.5 days post-coitum, whereas
          FSHR mRNA is absent at this stage of fetal development. We concluded that
          the pronounced regulation of LRPR1 by FSH observed in the immature rat
          testis does not occur in the ovary. Furthermore, in the ovary LRPR1 mRNA
          expression does not appear to be dependent on FSH action. Finally, the
          LRPR1 gene product may play a general role during fetal development.</description>
    </item> <item>
      <title>Alternative splicing of follicle-stimulating hormone receptor pre-mRNA: cloning and characterization of two alternatively spliced mRNA transcripts (Article)</title>
      <link>http://repub.eur.nl/res/pub/8888/</link>
      <pubDate>1998-01-01T00:00:00Z</pubDate>
      <description>Glycoprotein hormone receptors contain a large extracellular domain that
          is encoded by multiple exons, facilitating the possibility of expressing
          alternatively spliced transcripts. We have cloned two new splice variants
          of the rat follicle-stimulating hormone (FSH) receptor gene: FSH-R1 and
          FSH-R2. The splice variant FSH-R1 differs from the full-length FSH
          receptor mRNA by the inclusion of a small extra exon between exons 9 and
          10. FSH-R2 lacks the first three base pairs of exon 4, contains an extra
          exon between exons 4 and 5, and has an extended 3'-untranslated region.
          According to the predicted open reading frames, both mRNAs encode
          truncated FSH receptor proteins, consisting of the entire extracellular
          domain (FSH-R1) or the amino-terminal half of the extracellular domain
          (FSH-R2), and are expressed at a low level in testes and ovaries. The
          levels of expression of the FSH-R1 and FSH-R2 mRNAs in the gonads show a
          constant ratio to the expression level of the full-length FSH receptor
          mRNA. Furthermore, in vitro co-expression of either one of the truncated
          proteins with the full-length FSH receptor in COS1 cells did not affect
          signal transduction through the full-length FSH receptor. The absence of a
          function of the truncated FSH receptors in FSH signal transduction in
          vitro, and the lack of differential regulation of the alternative
          transcripts, indicate that there is no clear function for alternative
          splicing of the FSH receptor pre-mRNA in the postnatal testis and the
          cycling adult ovary.</description>
    </item> <item>
      <title>Effect of prenatal exposure to diethylstilbestrol on Mullerian duct development in fetal male mice (Article)</title>
      <link>http://repub.eur.nl/res/pub/8903/</link>
      <pubDate>1998-01-01T00:00:00Z</pubDate>
      <description>The clinical use of diethylstilbestrol (DES) by pregnant women has
          resulted in an increased incidence of genital carcinoma in the daughters
          born from these pregnancies. Also, in the so-called DES-sons abnormalities
          were found, mainly, the presence of Mullerian duct remnants, which
          indicates that fetal exposure to DES may have an effect on male sex
          differentiation. Fetal regression of the Mullerian ducts is under
          testicular control through anti-Mullerian hormone (AMH). In male mice,
          treated in utero with DES, the Mullerian ducts do not regress completely,
          although DES-exposed testes do produce AMH. We hypothesized that
          incomplete regression in DES-exposed males is caused by a diminished
          sensitivity of the Mullerian ducts to AMH. Therefore, the effect of DES on
          temporal aspects of Mullerian duct regression and AMH type II receptor
          (AMHRII) messenger RNA (mRNA) expression in male mouse fetuses was
          studied. It was observed that Mullerian duct regression was incomplete at
          E19 (19 days post coitum), upon DES administration during pregnancy from
          E9 through E16. Furthermore, analysis of earlier time points of fetal
          development revealed that the DES treatment had clearly delayed the onset
          of Mullerian duct formation by approximately 2 days; in untreated fetuses,
          Mullerian duct formation was complete by E13, whereas fully formed
          Mullerian ducts were not observed in DES-treated male fetuses until E15.
          Using in situ hybridization, no change in the localization of AMH and
          AMHRII mRNA expression was observed in DES-exposed male fetuses. The mRNA
          expression was quantified using ribonuclease protection assay, showing an
          increased expression level of AMH and AMHRII mRNAs at E 13 in DES-exposed
          male fetuses. Furthermore, the mRNA expression levels of Hoxa 11 and
          steroidogenic factor-1 (SF-1) were determined as a marker for fetal
          development. Prenatal DES exposure had no effect on Hoxa 11 mRNA
          expression, indicating that DES did not exert an overall effect on the
          rate of fetal development. In DES-exposed male fetuses, SF-1 showed a
          similar increase in mRNA expression as AMH, in agreement with the
          observations that the AMH gene promoter requires an intact SF-1 DNA
          binding site for time- and cell-specific expression, although an effect of
          DES on SF-1 expression in other tissues, such as the adrenal and pituitary
          gland, cannot be excluded. However, the increased expression levels of AMH
          and AMHRII mRNAs do not directly explain the decreased sensitivity of the
          Mullerian ducts to AMH. Therefore, it is concluded that prenatal DES
          exposure of male mice delays the onset of Mullerian duct development,
          which may result in an asynchrony in the timing of Mullerian duct
          formation, with respect to the critical period of Mullerian duct
          regression, leading to persistence of Mullerian duct remnants in male
          mice.</description>
    </item> <item>
      <title>Molecular analysis of the androgen-receptor gene in a family with receptor-positive partial androgen insensitivity: an unusual type of intronic mutation (Article)</title>
      <link>http://repub.eur.nl/res/pub/8726/</link>
      <pubDate>1997-01-01T00:00:00Z</pubDate>
      <description>In the coding part and the intron-exon boundaries of the androgen-receptor
          gene of a patient with partial androgen insensitivity, no mutation was
          found. The androgen receptor of this patient displayed normal
          ligand-binding parameters and migrated as a 110-112-kD doublet on SDS-PAGE
          in the absence of hormone. However, after culturing of the patient's
          genital skin fibroblasts in the presence of hormone, the slower-migrating
          114-kD protein, which reflects hormone-dependent phosphorylation, was
          hardly detectable. Furthermore, receptor protein was undetectable in the
          nuclear fraction of the fibroblasts, after treatment with hormone, which
          is indicative of defective DNA binding. By sequencing part of intron 2, a
          T--&gt;A mutation was found 11 bp upstream of exon 3. In our screening of 102
          chromosomes from unrelated individuals, this base-pair substitution was
          not found, indicating that it was not a polymorphism. mRNA analysis
          revealed that splicing involved a cryptic splice site, located 71/70 bp
          upstream of exon 3, resulting in generation of mRNA with an insert of 69
          nucleotides. In addition, a small amount of a transcript with a deleted
          exon 3 and a very low level of wild-type transcript were detected.
          Translation of the extended transcript resulted in an androgen-receptor
          protein with 23 amino acid residues inserted between the two zinc
          clusters, displaying defective DNA binding and defective transcription
          activation.</description>
    </item> <item>
      <title>Inactivation of the HR6B ubiquitin-conjugating DNA repair enzyme in mice causes male sterility associated with chromatin modification. (Article)</title>
      <link>http://repub.eur.nl/res/pub/3103/</link>
      <pubDate>1996-09-06T00:00:00Z</pubDate>
      <description>The ubiquitin-conjugating yeast enzyme RAD6 and its human homologs hHR6A and hHR6B are implicated in postreplication repair and damage-induced mutagenesis. The yeast protein is also required for sporulation and may modulate chromatin structure via histone ubiquitination. We report the phenotype of the first animal mutant in the ubiquitin pathway: inactivation of the hHR6B-homologous gene in mice causes male infertility. Derailment of spermatogenesis becomes overt during the postmeiotic condensation of chromatin in spermatids. These findings provide a parallel between yeast sporulation and mammalian spermatogenesis and strongly implicate hHR6-dependent ubiquitination in chromatin remodeling. Since heterozygous male mice and even knockout female mice are completely normal and fertile and thus able to transmit the defect, similar hHR6B mutations may cause male infertility in man.</description>
    </item> <item>
      <title>Expression of the ubiquitin-conjugating DNA repair enzymes HHR6A and B suggests a role in spermatogenesis and chromatin modification. (Article)</title>
      <link>http://repub.eur.nl/res/pub/3093/</link>
      <pubDate>1996-01-10T00:00:00Z</pubDate>
      <description>RAD6, a member of the expanding family of ubiquitin-conjugating (E2) enzymes, functions in the so-called "N-rule" protein breakdown pathway of Saccharomyces cerevisiae. In vitro, the protein can attach one or multiple ubiquitin (Ub) moieties to histones H2A and B and trigger their E3-dependent degradation. Rad6 mutants display a remarkably pleiotropic phenotype, implicating the protein in DNA damage-induced mutagenesis, postreplication repair, repression of retrotransposition, and sporulation. RAD6 transcription is strongly induced upon UV exposure and in meiosis, suggesting that it is part of a damage-induced response pathway and that it is involved in meiotic recombination. It is postulated that the protein exerts its functions by modulating chromatin structure. Previously, we have cloned two human homologs of this gene (designated HHR6A and HHR6B) and demonstrated that they partially complement the yeast defect. Here we present a detailed characterisation of their expression at the transcript and protein levels. Both HHR6 proteins, resolved by 2-dimensional immunoblot analysis, are expressed in all mammalian tissues and cell types examined, indicating that both genes are functional and constitutively expressed. Although the proteins are highly conserved, the UV induction present in yeast is not preserved, pointing to important differences in damage response between yeast and mammals. Absence of alterations in HHR6 transcripts or protein upon heat shock and during the cell cycle suggests that the proteins are not involved in stress response or cell cycle regulation. Elevated levels of HHR6 transcripts and proteins were found in testis. Enhanced HHR6 expression did not coincide with meiotic recombination but with the replacement of histones by transition proteins. Immunohistochemistry demonstrated that the HHR6 proteins are located in the nucleus, consistent with a functional link with chromatin. Electron microscopy combined with immunogold labeling revealed a preferential localisation of HHR6 in euchromatin areas, suggesting that the protein is associated with transcriptionally active regions. Our findings support the idea that both HHR6 genes have overlapping, constitutive functions related to chromatin conformation and that they have a specific role in spermatogenesis, involving Ub-mediated histone degradation.</description>
    </item> <item>
      <title>Postmeiotic transcription of X and Y chromosomal genes during spermatogenesis in the mouse. (Article)</title>
      <link>http://repub.eur.nl/res/pub/3081/</link>
      <pubDate>1995-08-01T00:00:00Z</pubDate>
      <description>During the meiotic prophase of spermatogenesis, the X and Y chromosomes form the heterochromatic sex body, showing little transcriptional activity. It has been suggested that transcription of the Xist gene is involved in this inactivation. After completion of the meiotic divisions, at least two Y chromosomal genes, Zfy and Sry, are transcribed in haploid spermatids. In contrast, postmeiotic transcription of X chromosomal genes has not been demonstrated. Using highly purified preparations of mouse pachytene spermatocytes, round spermatids, and cytoplasmic fragments from elongated spermatids, the present experiments show differential postmeiotic expression of the Y chromosomal genes Ubely and Sry, with highest mRNA levels in round spermatids and cytoplasmic fragments, respectively. Postmeiotic transcription of the X chromosomal gene Ube1x is indicated by an increased level of Ube1x mRNA in round spermatids and cytoplasmic fragments. The X chromosomal gene MHR6A shows a marked temporary postmeiotic expression in round spermatids. This postmeiotic activity of the X chromosome is a novel finding, which may have implications for our understanding of X chromosome inactivation during spermatogenesis and paternal genome imprinting.</description>
    </item> <item>
      <title>Transcriptional regulation of androgen receptor gene expression in Sertoli cells and other cell types (Article)</title>
      <link>http://repub.eur.nl/res/pub/8883/</link>
      <pubDate>1992-01-01T00:00:00Z</pubDate>
      <description>Cooperative actions of FSH and androgens on initiation, maintenance, and
      restoration of spermatogenesis have been described. In the present
      experiments the regulatory effects of FSH on androgen receptor (AR) gene
      expression in Sertoli cells were studied. In immature rats injection of
      FSH (1 microgram/g BW, ip) resulted in a rapid down-regulation of
      testicular AR mRNA expression (4 h), followed by recovery to the control
      level (10 h). Using cultured immature Sertoli cells, a similar transient
      effect on AR mRNA expression was observed after the addition of FSH (500
      ng/ml) or (Bu)2cAMP (0.5 mM). Cycloheximide treatment of the cells did not
      prevent the rapid FSH-induced down-regulation of AR mRNA expression,
      indicating that de novo protein synthesis is not required for this effect.
      Furthermore, using a transcriptional run-on assay, no marked decrease in
      the rate of AR gene transcription was found upon treatment of the cultured
      Sertoli cells with FSH for 2 or 4 h. This demonstrates that the short term
      effect of FSH or AR mRNA expression reflects a change in mRNA stability.
      The AR protein level was not markedly affected by the transient decrease
      in AR mRNA expression. When immature Sertoli cells were incubated with FSH
      for longer time periods (24-72 h), both AR mRNA and protein expression
      were increased. In Sertoli cells isolated from 15-day-old rats, this
      increase was higher (mRNA, 2- to 3-fold; protein, 2-fold) than in Sertoli
      cells isolated from 25-day-old animals. The results indicate that FSH
      plays a complex role in the regulation of AR expression in immature rat
      Sertoli cells</description>
    </item> <item>
      <title>Transient down-regulation of androgen receptor messenger ribonucleic acid (mRNA) expression in Sertoli cells by follicle-stimulating hormone is followed by up-regulation of androgen receptor mRNA and protein (Article)</title>
      <link>http://repub.eur.nl/res/pub/8886/</link>
      <pubDate>1992-01-01T00:00:00Z</pubDate>
      <description>In Sertoli cells from 21-day-old rats, the expression of the mRNA encoding
      the alpha-subunit of inhibin, and the production of immunoreactive inhibin
      are stimulated by follicle-stimulating hormone (FSH). In contrast, the
      amount of beta B-subunit mRNA is not increased after FSH treatment of the
      cells, and the ratio between bioactive and immunoactive inhibin decreases
      after stimulation with FSH. These data suggest that the beta B-subunit is
      the limiting factor in the production of bioactive inhibin. The aim of the
      present experiments was to investigate the effect of changes in the amount
      of beta B-subunit mRNA on the production of bioactive and immunoreactive
      inhibin. During early postnatal testicular development, the relative
      amounts of the 4.2 kb and 3.5 kb mRNAs encoding the beta B-subunit of
      inhibin changed markedly. The meaning of this changing ratio between beta
      B-subunit mRNAs is not clear, since both mRNAs are actively translated, as
      demonstrated by polysomal analysis. The total amount of beta B-subunit
      mRNA correlated with the in vitro production of bioactive inhibin as
      published earlier. Prolonged stimulation of cultured Sertoli cells from
      14-day-old rats with 4 beta-phorbol 12-myristate 13-acetate (PMA) caused a
      decreased expression of the beta B-subunit mRNAs, presumably by
      down-regulation of protein kinase C. A similar effect was obtained after
      addition of the calcium ionophore A23187. Concomitantly, a decreased
      production of bioactive inhibin was observed. Furthermore, Western
      blotting revealed that secretion of the 32 kDa inhibin alpha beta-dimer
      was decreased, whereas secretion of the combination of the C-terminal part
      with the pro-region of the alpha-subunit was increased. It is concluded
      that the level of the beta B-subunit of inhibin is rate-limiting for the
      production of bioactive inhibin in cultured Sertoli cells, and that its
      expression can be influenced by modulation of protein kinase C, and/or
      intracellular calcium levels.</description>
    </item> <item>
      <title>Follitropin receptor down-regulation involves a cAMP-dependent post-transcriptional decrease of receptor mRNA expression (Article)</title>
      <link>http://repub.eur.nl/res/pub/8887/</link>
      <pubDate>1991-01-01T00:00:00Z</pubDate>
      <description>The androgen receptor (AR) is activated upon binding of testosterone or
      dihydrotestosterone and exerts regulatory effects on gene expression in
      androgen target cells. To study transcriptional regulation of the rat AR
      gene itself, the 5' genomic region of this gene was cloned from a genomic
      library and the promoter was identified. S1-nuclease protection analysis
      showed two major transcription start sites, located between 1010 and 1023
      bp upstream from the translation initiation codon. The area surrounding
      these start sites was cloned in both orientations in a CAT reporter
      plasmid. Upon transfection of the constructs into COS cells, part of the
      promoter stimulated transcription in an orientation-independent manner,
      but the full promoter showed a higher and unidirectional activity. In the
      promoter/reporter gene constructs, transcription initiated from the same
      positions as in the native gene. Sequence analysis showed that the
      promoter of the rat AR gene lacks typical TATA and CCAAT box elements, but
      one SP1 site is located at about 60 bp upstream from the major start site
      of transcription. Other possible promoter elements are TGTYCT sequences at
      positions -174 to -179, -434 to -439., -466 to -471, and -500 to -505,
      resembling half-sites of the glucocorticoid-responsive element (GRE).
      Furthermore, a homopurine stretch containing a total of 8 GGGGA elements
      and similar to sequences that are present in several other GC-rich
      promoters, is located between -89 and -146 bp upstream from the major
      start site of transcription.</description>
    </item> <item>
      <title>The rat androgen receptor gene promoter (Article)</title>
      <link>http://repub.eur.nl/res/pub/8890/</link>
      <pubDate>1990-01-01T00:00:00Z</pubDate>
      <description>The androgen receptor (AR) is activated upon binding of testosterone or
      dihydrotestosterone and exerts regulatory effects on gene expression in
      androgen target cells. To study transcriptional regulation of the rat AR
      gene itself, the 5' genomic region of this gene was cloned from a genomic
      library and the promoter was identified. S1-nuclease protection analysis
      showed two major transcription start sites, located between 1010 and 1023
      bp upstream from the translation initiation codon. The area surrounding
      these start sites was cloned in both orientations in a CAT reporter
      plasmid. Upon transfection of the constructs into COS cells, part of the
      promoter stimulated transcription in an orientation-independent manner,
      but the full promoter showed a higher and unidirectional activity. In the
      promoter/reporter gene constructs, transcription initiated from the same
      positions as in the native gene. Sequence analysis showed that the
      promoter of the rat AR gene lacks typical TATA and CCAAT box elements, but
      one SP1 site is located at about 60 bp upstream from the major start site
      of transcription. Other possible promoter elements are TGTYCT sequences at
      positions -174 to -179, -434 to -439., -466 to -471, and -500 to -505,
      resembling half-sites of the glucocorticoid-responsive element (GRE).
      Furthermore, a homopurine stretch containing a total of 8 GGGGA elements
      and similar to sequences that are present in several other GC-rich
      promoters, is located between -89 and -146 bp upstream from the major
      start site of transcription</description>
    </item> <item>
      <title>Hormones and the control of biochemical processes in spermatogenesis (Doctoral Thesis)</title>
      <link>http://repub.eur.nl/res/pub/25954/</link>
      <pubDate>1978-06-07T00:00:00Z</pubDate>
      <description>The aim of the experiments described in this thesis was
to contribute to a better understanding of the relationship,
in molecular terms, between hormones and the development of
male germinal cells in rats. In this introduction we will
discuss some important aspects of spermatogenesis, the hormonal
control of spermatogenesis, and the aim and scope of the
present thesis.</description>
    </item>
  </channel>
</rss>